United States - English - NLM (National Library of Medicine)

st. renatus - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv), oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - tetracaine hydrochloride 30 mg in 1 ml - kovanaze tm is indicated for regional anesthesia when performing a restorative procedure on teeth 4-13 and a-j in adults and children who weigh 40 kg or more. kovanaze is contraindicated in patients with a history of allergy to or intolerance of tetracaine, benzyl alcohol, other ester local anesthetics, p -aminobenzoic acid (paba), oxymetazoline, or any other component of the product [see warnings and precautions ( 5.5)] . risk summary limited published data on tetracaine use in pregnant women are not sufficient to inform any risks. published epidemiologic studies of nasal oxymetazoline used as a decongestant during pregnancy do not identify a consistent association with any specific malformation or pattern of malformations [see data] . in animal reproduction and development studies, oxymetazoline given subcutaneously to rats during the period of organogenesis caused structural abnormalities at a dose approximately 7.6 times the exposure

United States - English - NLM (National Library of Medicine)

akorn - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride 10 mg in 1 ml - tetracaine hydrochloride is indicated for the production of spinal anesthesia for procedures requiring two to three hours. spinal anesthesia with tetracaine hydrochloride is contraindicated in patients with known hypersensitivity to tetracaine hydrochloride or to drugs of a similar chemical configuration (ester-type local anesthetics), or aminobenzoic acid or its derivatives; and in patients for whom spinal anesthesia as a technique is contraindicated. the decision as to whether or not spinal anesthesia should be used for an individual patient should be made by the physician after weighing the advantages with the risks and possible complications. contraindications to spinal anesthesia as a technique can be found in standard reference texts, and usually include generalized septicemia, infection at the site of injection, certain diseases of the cerebrospinal system, uncontrolled hypotension, etc.

United States - English - NLM (National Library of Medicine)

amd medicom inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 0.18 g in 1 g - indication: for rapid and long lasting topical anesthesia direction: apply 0.2ml of gel to the desired area using a cotton swab active ingredient: benzocaine 18.0% w/w, tetracaine hydrochloride 2.0% w/w

United States - English - NLM (National Library of Medicine)

amd medicom inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 0.18 g in 1 g - indication: for rapid and long lasting topical anesthesia direction: apply 0.2 ml of gel to the desired area using a cotton swab active ingredient: benzocaine 18.0% w/w, tetracaine hydrochloride 2.0% w/w

United States - English - NLM (National Library of Medicine)

amd medicom inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 0.18 g in 1 g - indication: for rapid and long lasting topical anesthesia direction: apply 0.2ml of gel to the desired area using a cotton swab active ingredient: benzocaine 18.0% w/w, tetracaine hydrochloride 2.0% w/w

United States - English - NLM (National Library of Medicine)

amd medicom inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 0.18 g in 1 g - indication: for rapid and long lasting topical anesthesia direction: apply 0.2ml of gel to the desired area using a cotton swab active ingredient: benzocaine 18.0% w/w, tetracaine hydrochloride 2.0% w/w

United States - English - NLM (National Library of Medicine)

amd medicom inc. - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - benzocaine 0.18 g in 1 g - indications: for rapid and long lasting topical anesthesia directions: apply 0.2ml of gel to the desired area using a cotton swab active ingredients: benzocaine 18.0% w/w, tetracaine hydrochloride 2.0% w/w

United States - English - NLM (National Library of Medicine)

cameron pharmaceuticals - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride is indicated for the production of spinal anesthesia for procedures requiring two to three hours. spinal anesthesia with tetracaine hydrochloride is contraindicated in patients with known hypersensitivity to tetracaine hydrochloride or to drugs of a similar chemical configuration (ester-type local anesthetics), or aminobenzoic acid or its derivatives; and in patients for whom spinal anesthesia as a technique is contraindicated. the decision as to whether or not spinal anesthesia should be used for an individual patient should be made by the physician after weighing the advantages with the risks and possible complications. contraindications to spinal anesthesia as a technique can be found in standard reference texts, and usually include generalized septicemia, infection at the site of injection, certain diseases of the cerebrospinal system, uncontrolled hypotension, etc.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride is indicated for the production of spinal anesthesia for procedures requiring two to three hours. spinal anesthesia with tetracaine hydrochloride is contraindicated in patients with known hypersensitivity to tetracaine hydrochloride or to drugs of a similar chemical configuration (ester-type local anesthetics), or aminobenzoic acid or its derivatives; and in patients for whom spinal anesthesia as a technique is contraindicated. the decision as to whether or not spinal anesthesia should be used for an individual patient should be made by the physician after weighing the advantages with the risks and possible complications. contraindications to spinal anesthesia as a technique can be found in standard reference texts, and usually include generalized septicemia, infection at the site of injection, certain diseases of the cerebrospinal system, uncontrolled hypotension, etc.

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride 5 mg in 1 ml - tetracaine hydrochloride ophthalmic solution 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. none. risk summary there are no adequate and well-controlled studies with tetracaine hydrochloride ophthalmic solution 0.5% in pregnant women.  animal developmental and reproductive toxicity studies with tetracaine hydrochloride have not been reported in the published literature. risk summary there are no data to assess whether tetracaine hydrochloride ophthalmic solution 0.5% is excreted in human milk or to assess its effects on milk production/excretion.  the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for tetracaine hydrochloride ophthalmic solution 0.5% and any potential adverse effects on the breastfed child from tetracaine hydrochloride ophthalmic solution 0.5% or from the underlying maternal condition. no human data on the effect of tetracaine hydrochloride ophthalmic solution 0.5% on fertility are available. safety in the pediatric population has been demonstrated in clinical trials.  efficacy of tetracaine hydrochloride ophthalmic solution for use in pediatric patients has been extrapolated from adequate and well controlled clinical trials in the adult population. no overall differences in safety or effectiveness of tetracaine hydrochloride ophthalmic solution have been observed between elderly and younger patients.